Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896833968> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2896833968 abstract "As biomarkers are increasingly being used as screening, target engagement, and/or outcome measures in clinical trials, automated assay platforms are being developed to optimize analytical performance. Validation of the clinicopathologic utility of such assays is critical for bringing such assays into the clinical space. Thus, we evaluated the correspondence between CSF Ab1-42 and total tau measured with the automated LUMIPULSE G1200 platform, the manual INNOTEST® ELISAs, and in vivo b-amyloid positron emission tomography (PET). CSF samples from 198 participants at the Knight Alzheimer's Disease Research Center at Washington University who underwent amyloid imaging with Pittsburgh Compound B (PIB) within 12 months of CSF collection were analyzed by the automated Lumipulse G β-Amyloid 1-42 and Total Tau assays and manual INNOTEST β-Amyloid(1-42), β-Amyloid(1-40), and hTau assays (Fujirebio Europe). Values for each biomarker and ratios of Aβ1-42/Aβ1-40 and Tau/Aβ1-42 that corresponded best to PIB-positivity (SUVR >1.42) were determined using receiver operating characteristic (ROC) analyses. Cutoff values with the highest Youden index (maximizing sensitivity and specificity) were established for all measures, and optimal concordance at these cutoffs were determined using area under the ROC curve (AUC) analyses. Lumipulse and INNOTEST assays were positively correlated (Ab1-42 Spearman r=0.834; Tau r=0.858, p's<0.0001). Within-sample (n=5-7) reproducibility of a common CSF sample was high (% coefficients of variation [%CV]: Lumipulse G β-Amyloid 1-42 [3.9%]; INNOTEST Ab1-42[5.4%]; INNOTEST Ab1-40[9.8%]; Lumipulse Total Tau [1.6%]; INNOTEST hTau [1.8%]). As expected, CSF Ab1-42 discriminated PIB-positive (n=50) from PIB-negative (n=148) individuals better than Ab1-40 (Lumipulse Ab1-42 AUC=0.83[95% CI, 0.77-0.89]; INNOTEST Ab1-42 AUC=0.88[0.83-0.94]; INNOTEST Ab1-40 AUC=0.57[0.48-0.67]). The Tau assays also discriminated between PIB groups (Lumipulse AUC=0.82[0.76-0.89]; INNOTEST AUC=0.86[0.80-0.92]). When in a ratio with INNOTEST Ab1-40, each Ab1-42 measure outperformed the single Ab1-42 value (Lumipulse Ab1-42/INNOTEST Ab1-40 AUC=0.91[0.85-0.96]; INNOTEST Ab1-42/INNOTEST Ab1-40 AUC=0.88[0.82-0.94]). Furthermore, the Tau/Ab1-42 ratios performed the best for PIB discrimination (Lumipulse AUC=0.94[0.91-0.97]; INNOTEST AUC=0.96[0.94-0.99]). The automated Lumipulse G assays for Ab1-42 and Total Tau showed excellent within-sample reproducibility (%CV<4%) and performed well in discriminating amyloid groups (AUCs=0.82-0.83), especially when put into a ratio (AUC=0.94). These ratios may be useful for enrollment of amyloid-positive individuals into clinical trials." @default.
- W2896833968 created "2018-10-26" @default.
- W2896833968 creator A5000597778 @default.
- W2896833968 creator A5006234374 @default.
- W2896833968 creator A5015035729 @default.
- W2896833968 creator A5020240274 @default.
- W2896833968 creator A5025837253 @default.
- W2896833968 creator A5027300987 @default.
- W2896833968 creator A5031918039 @default.
- W2896833968 creator A5063197083 @default.
- W2896833968 creator A5063630764 @default.
- W2896833968 creator A5089329008 @default.
- W2896833968 creator A5090741969 @default.
- W2896833968 creator A5091383045 @default.
- W2896833968 date "2018-07-01" @default.
- W2896833968 modified "2023-10-16" @default.
- W2896833968 title "P1‐290: CONCORDANCE BETWEEN <i>IN VIVO</i> AMYLOID IMAGING AND CSF AB <sub>1‐42</sub> AND TOTAL TAU MEASURED BY THE AUTOMATED LUMIPULSE <sup>®</sup> G ASSAY PLATFORM" @default.
- W2896833968 doi "https://doi.org/10.1016/j.jalz.2018.06.296" @default.
- W2896833968 hasPublicationYear "2018" @default.
- W2896833968 type Work @default.
- W2896833968 sameAs 2896833968 @default.
- W2896833968 citedByCount "0" @default.
- W2896833968 crossrefType "journal-article" @default.
- W2896833968 hasAuthorship W2896833968A5000597778 @default.
- W2896833968 hasAuthorship W2896833968A5006234374 @default.
- W2896833968 hasAuthorship W2896833968A5015035729 @default.
- W2896833968 hasAuthorship W2896833968A5020240274 @default.
- W2896833968 hasAuthorship W2896833968A5025837253 @default.
- W2896833968 hasAuthorship W2896833968A5027300987 @default.
- W2896833968 hasAuthorship W2896833968A5031918039 @default.
- W2896833968 hasAuthorship W2896833968A5063197083 @default.
- W2896833968 hasAuthorship W2896833968A5063630764 @default.
- W2896833968 hasAuthorship W2896833968A5089329008 @default.
- W2896833968 hasAuthorship W2896833968A5090741969 @default.
- W2896833968 hasAuthorship W2896833968A5091383045 @default.
- W2896833968 hasConcept C126322002 @default.
- W2896833968 hasConcept C142724271 @default.
- W2896833968 hasConcept C160798450 @default.
- W2896833968 hasConcept C185592680 @default.
- W2896833968 hasConcept C2775842073 @default.
- W2896833968 hasConcept C2781197716 @default.
- W2896833968 hasConcept C2989005 @default.
- W2896833968 hasConcept C43346845 @default.
- W2896833968 hasConcept C43617362 @default.
- W2896833968 hasConcept C55493867 @default.
- W2896833968 hasConcept C58471807 @default.
- W2896833968 hasConcept C71924100 @default.
- W2896833968 hasConcept C9893847 @default.
- W2896833968 hasConceptScore W2896833968C126322002 @default.
- W2896833968 hasConceptScore W2896833968C142724271 @default.
- W2896833968 hasConceptScore W2896833968C160798450 @default.
- W2896833968 hasConceptScore W2896833968C185592680 @default.
- W2896833968 hasConceptScore W2896833968C2775842073 @default.
- W2896833968 hasConceptScore W2896833968C2781197716 @default.
- W2896833968 hasConceptScore W2896833968C2989005 @default.
- W2896833968 hasConceptScore W2896833968C43346845 @default.
- W2896833968 hasConceptScore W2896833968C43617362 @default.
- W2896833968 hasConceptScore W2896833968C55493867 @default.
- W2896833968 hasConceptScore W2896833968C58471807 @default.
- W2896833968 hasConceptScore W2896833968C71924100 @default.
- W2896833968 hasConceptScore W2896833968C9893847 @default.
- W2896833968 hasIssue "7S_Part_7" @default.
- W2896833968 hasLocation W28968339681 @default.
- W2896833968 hasOpenAccess W2896833968 @default.
- W2896833968 hasPrimaryLocation W28968339681 @default.
- W2896833968 hasRelatedWork W1964605686 @default.
- W2896833968 hasRelatedWork W1992168087 @default.
- W2896833968 hasRelatedWork W2061304069 @default.
- W2896833968 hasRelatedWork W2070705913 @default.
- W2896833968 hasRelatedWork W2181480125 @default.
- W2896833968 hasRelatedWork W2568698376 @default.
- W2896833968 hasRelatedWork W2914849423 @default.
- W2896833968 hasRelatedWork W2918454308 @default.
- W2896833968 hasRelatedWork W3116991131 @default.
- W2896833968 hasRelatedWork W3153372042 @default.
- W2896833968 hasVolume "14" @default.
- W2896833968 isParatext "false" @default.
- W2896833968 isRetracted "false" @default.
- W2896833968 magId "2896833968" @default.
- W2896833968 workType "article" @default.